A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
Intima Bioscience, Inc.
Intima Bioscience, Inc.
Shanghai Zhongshan Hospital
Elicio Therapeutics
CHA University
Merck Sharp & Dohme LLC
Leap Therapeutics, Inc.
Samsung Medical Center
TransThera Sciences (Nanjing), Inc.
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Ohio State University Comprehensive Cancer Center
Seoul National University Hospital
DxTerity Diagnostics
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
TransThera Sciences (Nanjing), Inc.
National Cancer Institute (NCI)
University of Nebraska
Imperial College London
University of Nebraska
European Organisation for Research and Treatment of Cancer - EORTC
EMD Serono
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mayo Clinic
Mayo Clinic
M.D. Anderson Cancer Center
AIO-Studien-gGmbH
University of Chicago
The Christie NHS Foundation Trust
Osmania Medical College
Wake Forest University Health Sciences
Oita Red Cross Hospital
MacroGenics
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Sanjay Gandhi Postgraduate Institute of Medical Sciences
H. Lee Moffitt Cancer Center and Research Institute
Fuda Cancer Hospital, Guangzhou
H. Lee Moffitt Cancer Center and Research Institute
ASLAN Pharmaceuticals
Govind Ballabh Pant Institute of Postgraduate Medical Education and Research
ASLAN Pharmaceuticals
Eli Lilly and Company
Abramson Cancer Center at Penn Medicine
University of Chicago
Dr. Ersin Arslan Education and Training Hospital
Canadian Cancer Trials Group
The Christie NHS Foundation Trust
Swiss Cancer Institute